FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

13 results

belbuca
(buprenorphine hydrochloride)
BioDelivery Sciences International Inc
Usage: BELBUCA is indicated for the management of severe and persistent pain requiring long-term opioid treatment when alternative options are inadequate. It is not recommended for as-needed use and should be reserved for patients for whom other treatments have failed or are unsuitable.
brixadi
(BUPRENORPHINE)
Braeburn Inc.
Usage: BRIXADI is indicated for treating moderate to severe opioid use disorder in patients who have started with a single dose of transmucosal buprenorphine or are already on buprenorphine. It should be used alongside a comprehensive treatment plan, including counseling and psychosocial support.
buprenorphine
(Buprenorphine)
Amneal Pharmaceuticals NY LLC
Usage: Buprenorphine transdermal system is indicated for managing severe, persistent pain requiring long-term opioid treatment when alternative options are insufficient. It is not suitable for as-needed analgesic use and is reserved for patients who cannot tolerate or achieve adequate pain control with other treatments due to risks of addiction and overdose.
buprenorphine
(Buprenorphine)
Actavis Pharma, Inc.
Usage: Buprenorphine sublingual tablets are indicated for the treatment of opioid dependence, primarily for induction. They should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
buprenorphine and naloxone
(Buprenorphine and Naloxone)
Dr.Reddys Laboratories Inc
Usage: Buprenorphine and naloxone sublingual film is indicated for the treatment of opioid dependence, to be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
buprenorphine and naloxone
(Buprenorphine and Naloxone)
Dr.Reddys Laboratories Inc
Usage: Buprenorphine and naloxone sublingual film is indicated for the treatment of opioid dependence and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
buprenorphine hcl
(Buprenorphine HCl)
Hikma Pharmaceuticals USA Inc.
Usage: Buprenorphine Sublingual Tablets are indicated for treating opioid dependence, primarily during the induction phase. They should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
buprenorphine hydrochloride
(buprenorphine hydrochloride)
Advagen Pharma Ltd
Usage: Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence, specifically favored for induction. They should be part of a comprehensive treatment plan that includes counseling and psychosocial support.
buprenorphine hydrochloride
(Buprenorphine Hydrochloride)
ENDO USA, Inc.
Usage: Buprenorphine hydrochloride injection is indicated for managing severe pain requiring an opioid analgesic when alternative treatments are inadequate. It should be reserved for patients who cannot tolerate non-opioid options or when those options fail to provide sufficient pain relief.
buprenorphine hydrochloride
(Buprenorphine Hydrochloride)
Hospira, Inc.
Usage: Buprenorphine hydrochloride injection is indicated for managing severe pain that requires an opioid analgesic when alternative treatments are inadequate. It is reserved for cases where non-opioid options are intolerable or ineffective, and should not be used long-term unless pain severity persists.

Partial Opioid Agonist class drugs

belbuca

brixadi

buprenorphine

buprenorphine

buprenorphine and naloxone

buprenorphine and naloxone

buprenorphine hcl

buprenorphine hydrochloride

buprenorphine hydrochloride

buprenorphine hydrochloride